IGF2R antibody [MEM-238] (Biotin)
GTX28093-02
ApplicationsFlow Cytometry, ImmunoPrecipitation, Western Blot
Product group Antibodies
TargetIGF2R
Overview
- SupplierGeneTex
- Product NameIGF2R antibody [MEM-238] (Biotin)
- Delivery Days Customer9
- ApplicationsFlow Cytometry, ImmunoPrecipitation, Western Blot
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDMEM-238
- Concentration1 mg/ml
- ConjugateBiotin
- Gene ID3482
- Target nameIGF2R
- Target descriptioninsulin like growth factor 2 receptor
- Target synonymsCD222, CI-M6PR, CIMPR, M6P-R, M6P/IGF2R, MPR 300, MPR1, MPR300, MPRI, cation-independent mannose-6-phosphate receptor, 300 kDa mannose 6-phosphate receptor, CI Man-6-P receptor, IGF-II receptor, M6P/IGF2 receptor, insulin-like growth factor II receptor
- HostMouse
- IsotypeIgG1
- Protein IDP11717
- Protein NameCation-independent mannose-6-phosphate receptor
- Scientific DescriptionThis gene encodes a receptor for both insulin-like growth factor 2 and mannose 6-phosphate. The binding sites for each ligand are located on different segments of the protein. This receptor has various functions, including in the intracellular trafficking of lysosomal enzymes, the activation of transforming growth factor beta, and the degradation of insulin-like growth factor 2. Mutation or loss of heterozygosity of this gene has been association with risk of hepatocellular carcinoma. The orthologous mouse gene is imprinted and shows exclusive expression from the maternal allele; however, imprinting of the human gene may be polymorphic, as only a minority of individuals showed biased expression from the maternal allele (PMID:8267611). [provided by RefSeq, Nov 2015]
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Köseoğlu HG, Bozca BC, Başsorgun Cİ, et al. The role of insulin-like growth factor in Acrochordon Etiopathology. BMC Dermatol. 2020,20(1):14. doi: 10.1186/s12895-020-00111-0Read this paper
- Koeberl DD, Austin S, Case LE, et al. Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease. FASEB J. 2014,28(5):2171-6. doi: 10.1096/fj.13-241893Read this paper
- Li S, Sun B, Nilsson MI, et al. Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease. FASEB J. 2013,27(1):34-44. doi: 10.1096/fj.12-207472Read this paper
- Koeberl DD, Luo X, Sun B, et al. Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle. Mol Genet Metab. 2011,103(2):107-12. doi: 10.1016/j.ymgme.2011.02.006Read this paper




![FACS (intracellular staining) analysis of human peripheral blood using GTX28093-08 IGF2R antibody [MEM-238] (PE).](https://www.genetex.com/upload/website/prouct_img/normal/GTX28093-08/GTX28093-08_20191025_AP_006_203_w_23060722_726.webp)